ArticleTranslational pediatrics2024

Three-year update outcomes of the first chimeric antigen receptor-T therapy for children and young adults with relapsed/refractory acute lymphoblastic leukemia.

Hideki NakayamaPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.